Published on

CDSCO Manufacturing License for Haemodialyzer reprocessing system

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

The Central Drugs Standard Control Organization (CDSCO) is India's principal regulator for pharmaceuticals and medical devices. It functions under the Ministry of Health and Family Welfare, Government of India, responsible for quality control, approval of new drugs, and regulatory standards of imported drugs.

In the field of medical devices, one cannot downplay the significance of manufacturing licenses. They are critical factors for ensuring quality and safety in production. These licenses ascertain adherence to regulatory guidelines, protects patients and ensures the availability of safe medical devices. One such life-saving device is the Haemodialyzer reprocessing system, a critical equipment in Nephrology and Renal Care.

Please visit the CDSCO portal for more information on medical device regulations.

What is the Haemodialyzer Reprocessing System?

A Haemodialyzer reprocessing system is a medical device specifically designed to clean or rinse haemodialysis dialyzers after each use so that they can be reused. This device plays an integral role in Nephrology and Renal Care, ensuring dialyzers are effectively disinfected and safe for subsequent use.

The Role of CDSCO in Medical Device Regulation

The CDSCO plays a pivotal role in medical devices regulation in India. Its mission is to safeguard and enhance the public health by assuring safety, efficacy and quality of drugs, cosmetics and medical devices. It has a well-established regulatory framework for medical devices, categorizing them into four risk classes (A,B,C,D), with A being the lowest and D highest risk.

How to Manufacture Haemodialyzer Reprocessing System

In India, for manufacturing a Haemodialyzer reprocessing system, which falls under risk class C, a specific license is required.

Fees for Manufacturing License for Haemodialyzer Reprocessing System

The fees for the manufacturing license of a Haemodialyzer Reprocessing System falls under the license category MD9, with a base cost of Rs. 50,000 for the license and additional Rs. 1,000 per product.

Why is a Manufacturing License Necessary for Haemodialyzer Reprocessing System?

Adherence to legal permissions such as the mandatory manufacturing license ensures that medical devices adhere to the highest quality and safety standards. Regulatory compliance is significant to the healthcare sector as it directly affects public health. A license protects consumers and patients from substandard products ensuring only reputable and quality checked products reach them.

Steps to Obtain a CDSCO Manufacturing License for Haemodialyzer Reprocessing System

  1. Presubmission consultation and preparation of necessary documents like Device Master File, Quality Management Certificate, Device Details, Site details and more.
  2. Submission of the application and necessary documents to the CDSCO.
  3. The CDSCO will then review the application and documents, during which further clarification or additional information might be requested.
  4. Upon satisfactory review, the CDSCO will approve the application and issue the license.

To know more about securing a MD9 manufacturing license, read the detailed guide here

Frequently Asked Questions (FAQs)

  1. Q: What is the risk class of Haemodialyzer reprocessing system as per Medical Device Rules, 2017?

    A: The Haemodialyzer reprocessing system falls under Risk Class C.

  2. Q: What license is needed to manufacture a Haemodialyzer reprocessing system?

    A: To manufacture a Haemodialyzer reprocessing system, you need an MD9 license.

  3. Q: What is the fees for an MD9 license for a Haemodialyzer reprocessing system?

    A: The fees for an MD9 license is Rs. 50,000 plus an additional Rs. 1,000 per product.

  4. Q: Who will issue the manufacturing license for a Haemodialyzer reprocessing system?

    A: For class C devices like the Haemodialyzer reprocessing system, the CDSCO HQ in New Delhi will issue the license.

  5. Q: Is repackaging of the Haemodialyzer reprocessing system considered manufacturing?

    A: Yes, as per the Drugs and Cosmetics Act's definition of manufacturing, repackaging of drugs is considered manufacturing. By further definitions, medical devices are also drugs. Medical Device Rules have been made under the provisions of the Drug Act, and hence repackaging of the Haemodialyzer reprocessing system is also considered manufacturing requiring a license.

Conclusion

The process of obtaining a manufacturing license from the CDSCO can be intricate and demanding. Ensuring that all the prerequisites are fulfilled, all documents are correctly filled and submitted, and managing responses from the regulator can be challenging. Don't navigate this process alone! Reach out to our experts at Pharmadocx Consultants for consultation or assistance regarding the licensing process. Connect with us via our helpline number +91-7404557227 or send us an email at [email protected].

cdsco import license in india banner
cdsco manufacturing license in india banner